Diverse immunotherapies can effectively treat syngeneic brainstem tumors in the absence of overt toxicity

ConclusionsIt remains imperative to regard the brainstem with caution for immunotherapeutic intervention. Nonetheless, we show that further careful development of immunotherapies for pediatric brainstem tumors is warranted to harness the potential potency of anti-tumor immune responses, despite their possible toxicity within this anatomically sensitive location.
Source: Journal for Immunotherapy of Cancer - Category: Cancer & Oncology Source Type: research